Bayer Hemophilia Awards Program Bayer HealthCare
      ContactSitemapLanguage 
HomeAbout The Program
  Important updates
  Application Process
  Deadlines for Awards
  Review Process
  Research Priorities
  Past Award Recipients
  Past Award Recipients Archives
Bayer Links
   Bayer Global
   Bayer US
   Living with Haemophilia
   Kogenate FS
   General Conditions of Use
Regulatory Statement
Privacy Statement
Imprint




  2004 © Bayer HealthCare LLC

Bayer Hemophilia Awards recipients in 2006

Early Career Investigator Awards

  Conformational Regulation of von Willebrand Factor Function
Dr. Junmei Chen
Puget Sound Blood Center
Seattle, Washington, USA


A Disease-specific DNA Chip for von Willebrand Disease
Dr. Bradley Aouizerat
University of California San Francisco
San Francisco, California, USA


  Generation of Factor VIII-enhanced Green Fluorescent Protein (Factor VIII-EGFP)
Mr. Stefan Heinz
J.W. Goethe University
Frankfurt, Germany


Insights into Factor XI Processing and Function from the Study of the Molecular Basis of Factor XI Deficiency
Dr. Stefano Duga
Department of Biology and Genetics for Medical Sciences
Milan, Italy


  Prevalence of Inhibitors in Patients with Severe Hemophilia A in India: Impact of Clinical and Molecular Factors on Prevalence
Dr. Vikram Mathews
Christian Medical College
Vellore, India


Clinical Scholarship Awardees

Dr. Tina Dutt
Royal Liverpool & Broadgreen University Hospitals NHS Trust
Liverpool, UK


Dr. Antioco Meloni
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center
University of Milan
Milan, Italy


  Dr. Joannis Panotopoulos
Department of Orthopaedics
Medical University of Vienna
Vienna, Austria


Dr. Yi Fang
Ruijin Hospital
Shanghai Institute of Hematology
Shanghai, PR China


Dr. Hsuan-Yu Lin
Changhua Christian Hospital
Changhua, Taiwan


Special Projects

Diagnosis of Platelet Disorders Using a Proteomic Approach
Dr. Nigel Key
University of North Carolina
Chapel Hill, North Carolina, USA


Factor IX Molecules with Enhanced Activity
Dr. Dougald Monroe
University of North Carolina
Chapel Hill, North Carolina, USA


  Von Willebrand Factor as a Target to Prolong the Half-Life of Factor VIII
Dr. Peter Lenting
Unviersity Medical Center Utrecht
Utrecht, Netherlands


  A Multi-center Study on the Molecular Characterization of Haemophilia A Patients with Undetectable Mutations in the Factor VIII Gene
Prof. Johannes Oldenburg
University Clinic, University of Bonn
Bonn, Germany


Genetic Components Contributing to the Pharmacokinetics of Factor VIII Concentrates
Dr. Massimo Morfini
Azienda Ospedaliero - Universitaria Careggi
Firenze, Italy


The Effect of an Exercise Intervention on Quality of Life, Aerobic Fitness and Strength in Children with Hemophilia
Dr. Julie Curtin
Children's Hospital
Westmead, Australia


Applications of Laboratory Monitoring to Advance and Optimize the Treatment of Hemophilia A
Dr. Midori Shima
Nara Medical University
Nara, Japan


Caregiver Award

Assessing the Need for an HTC Alliance Between CHEO and the Baffin Regional Hospital
Diane Bissonnette
Children's Hospital of Eastern Ontario
Ottawa, Canada


  Training Nurses to Provide Hemophilia Care in India - A New Model
Mercy Devadarisini
Christian Medical College
Vellore, India


  Catch Them as Toddlers
Kumar Ajoy
Hemophilia Society - Durgapur Chapter
West Bengal, India


  Training in the Knowledge of Their Own Disease is the Best Tool the Patient, Family and Community Can Possess
Luz Garcia
Hospital del NiƱ6o
Panama, Republic of Panama


  Development of PWH Database Management Systems and Its Implementation in Hemophilia Management
Kumar Mitra and Kashinath Saha
The Haemophilia Society - Calcutta Chapter
West Bengal, India


  Training for Physical Therapy and Assessment of Musculoskeletal Outcome in People with Hemophilia
Andrew Babu Jayakumar
Christian Medical College
Vellore, India


  To Improve the Capacity and Quality of Laboratory Diagnosis of Coagulation Disorders in India
Gopal Singh
Christian Medical College
Vellore, India